Skip to content
10-Q

Quarterly Report

BLUEPRINT MEDICINES CORPORATION

0001558370-24-010615

← back to feed
Filed
Aug 1, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jul 30, 2024 63.35M sh
Stock Issued Q2 2024 · Jun 30, 2024 0 sh
Stock Issued Q2 2024 · Jun 30, 2024 544.72K sh
Stock Issued Q2 2024 · Jun 30, 2023 0 sh
Stock Issued Q2 2024 · Jun 30, 2023 0 sh
Shares Diluted Q2 2024 · Jun 30, 2024 62.85M sh
Shares Diluted Q2 2024 · Jun 30, 2024 64.61M sh
Shares Diluted Q2 2024 · Jun 30, 2023 60.52M sh
Shares Diluted Q2 2024 · Jun 30, 2023 60.32M sh
Capex Q2 2024 · Jun 30, 2024 $3.67M
Capex Q2 2024 · Jun 30, 2023 $5.14M
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$149.59M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$253.44M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $54.77M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $71.29M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $75.53M
Stockholders Equity Q2 2024 · Jun 30, 2024 $320.24M
Stockholders Equity Q2 2024 · Dec 31, 2023 $130.61M
Current Liabilities Q2 2024 · Jun 30, 2024 $243.8M
Current Liabilities Q2 2024 · Dec 31, 2023 $214.92M
Total Liabilities Q2 2024 · Jun 30, 2024 $883.32M
Total Liabilities Q2 2024 · Dec 31, 2023 $918.64M
Current Assets Q2 2024 · Jun 30, 2024 $903.54M
Current Assets Q2 2024 · Dec 31, 2023 $808.39M
Total Assets Q2 2024 · Jun 30, 2024 $1.2B
Total Assets Q2 2024 · Dec 31, 2023 $1.05B
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.80
Eps Diluted Q2 2024 · Jun 30, 2024 $0.61
Eps Diluted Q2 2024 · Jun 30, 2023 −$2.19
Eps Diluted Q2 2024 · Jun 30, 2023 −$4.35
Eps Basic Q2 2024 · Jun 30, 2024 −$0.80
Eps Basic Q2 2024 · Jun 30, 2024 $0.63
Eps Basic Q2 2024 · Jun 30, 2023 −$2.19
Eps Basic Q2 2024 · Jun 30, 2023 −$4.35
Sga Expense Q2 2024 · Jun 30, 2024 $89.34M
Sga Expense Q2 2024 · Jun 30, 2024 $172.9M
Sga Expense Q2 2024 · Jun 30, 2023 $71.93M
Sga Expense Q2 2024 · Jun 30, 2023 $142.88M
Rd Expense Q2 2024 · Jun 30, 2024 $84.27M
Rd Expense Q2 2024 · Jun 30, 2024 $172.46M
Rd Expense Q2 2024 · Jun 30, 2023 $110.06M
Rd Expense Q2 2024 · Jun 30, 2023 $222.14M
Net Income Q2 2024 · Jun 30, 2024 −$49.99M
Net Income Q2 2024 · Jun 30, 2024 $39.14M
Net Income Q2 2024 · Mar 31, 2024 $89.14M
Net Income Q2 2024 · Jun 30, 2023 −$132.79M
Net Income Q2 2024 · Jun 30, 2023 −$262.35M
Net Income Q2 2024 · Mar 31, 2023 −$129.56M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $7.59M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $10.79M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $2.32M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $5.5M